Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_assertion type Assertion NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_head.
- NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_assertion description "[IGRP inhibitors may be an attractive new approach for the treatment of insulin secretion defects in type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_provenance.
- NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_assertion evidence source_evidence_literature NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_provenance.
- NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_assertion SIO_000772 14722102 NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_provenance.
- NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_assertion wasDerivedFrom befree-2016 NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_provenance.
- NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_assertion wasGeneratedBy ECO_0000203 NP427925.RAbyEue0YBOVh1By_hD9TTXnE5GQYoFDBL9c-a_TdJcT8130_provenance.